Author:
Huntjens D R H,Strougo A,Chain A,Metcalf A,Summerfield S,Spalding D J M,Danhof M,Della Pasqua O
Reference32 articles.
1. Pharmacokinetics of intravenous luxabendazole in rabbits: influence of the enterohepatic circulation;Alvarez-Bujidos;Biopharm Drug Dispos,1998
2. Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques;Baillie;Drug Metab Dispos,2001
3. Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEM;Bressolle;J Pharmacokinet Biopharm,1998
4. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles;Chan;J Pharmacol Exp Ther,1999
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献